Kite Pharma, Inc.
Overview
Kite Pharma, a Gilead Company, is a biopharmaceutical company that specializes in the development of innovative cancer immunotherapies. Focused on chimeric antigen receptor (CAR) T cell therapies, Kite is committed to advancing breakthrough treatments for patients with hematological cancers.
Therapeutic areas
FDA compliance signals
7 FDA enforcement records linked to this company.
- 4832025-08-27
input/output verification
- 4832025-08-27
Written sanitation procedures lacking
- 4832025-08-27
Written record of investigation incomplete
- 4832025-08-27
Absence of Written Procedures
- 4832021-10-22
Environmental Monitoring System
- 4832019-08-20
SOPs not followed / documented
- 4832019-08-20
Test methods
Is this Kite Pharma, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.